Recent studies indicate an increased frequency of mutations in the gene encoding glucocerebrosidase (GBA), a deficiency of which causes Gaucher's disease, among patients with Parkinson's disease.
But for the GBA area, like Guangdong, they have a little bit more modernized abilities to deal with not only the medicine producing parts, but also some kind of research.